TUESDAY, Aug. 29, 2023 (HealthDay News) — Using ECMO, a highly advanced form of breathing support, does not appear to complicate treatment for obese adults in intensive care. ECMO, which is short for extracorporeal membrane oxygenation, may even help these patients when they experience respiratory failure, despite the fact thatContinue Reading
FRIDAY, Aug. 25, 2023 (HealthDay News) — Weight-loss drug Wegovy (semaglutide) and its diabetes-focused cousin, Ozempic, have already upended the treatment of both obesity and diabetes, with sales of both drugs skyrocketing. Now, injected Wegovy could prove a boon for many patients battling heart failure, a new study suggests. TheContinue Reading
MONDAY, Aug. 14, 2023 (HealthDay News) — A more personalized approach to exercise may be necessary, claims a new study that found fat burning varied widely between individuals. Even worse, this rate often does not align with the “fat-burning zone” on commercial exercise machines, the researchers added. Clinical exercise testing,Continue Reading
FRIDAY, Aug. 11, 2023 (HealthDay News) – As demand for the wildly popular weight-loss drug Wegovy continues to climb, drug maker Novo Nordisk said Thursday that it will continue restrictions on starter doses of the medication into 2024. The new plan extends by months existing restrictions and means patients whoContinue Reading
TUESDAY, Aug. 8, 2023 (HealthDay News) — A large clinical trial weighing the medical merits of the obesity drug Wegovy has unearthed a significant positive side effect. Taking the medication cut the risk of serious heart problems by 20%, drug maker Novo Nordisk announced Tuesday. “People living with obesity haveContinue Reading
MONDAY, Aug. 7, 2023 (HealthDay News) — In the midst of a childhood obesity epidemic, a new study is pointing to a way to help school kids maintain a healthier weight: clean, accessible drinking water. The decidedly low-tech solution emerged in a study of 18 California elementary schools that serveContinue Reading
THURSDAY, Aug. 3, 2023 (HealthDay News) — A Louisiana woman is suing the makers of two type 2 diabetes drugs used off-label for obesity, saying they failed to adequately warn about the risk of severe stomach problems. The lawsuit seeks “very significant” but unspecified compensation from the makers of bothContinue Reading
THURSDAY, Aug. 3, 2023 (HealthDay News) — More girls started puberty before age 8 during the COVID-19 pandemic, a phenomenon called precocious puberty, researchers say. The reasons include potential risk factors such as increased screen time and less exercise, according to a new study, published online Aug. 3 in theContinue Reading
MONDAY, July 31, 2023 (HealthDay News) — Some medications may not treat inflammatory bowel disease (IBD) as effectively if patients carry a lot of excess belly fat, , new research shows. IBD includes illnesses such as Crohn’s disease and ulcerative colitis. Researchers say using the wrong anti-inflammatory drug for theseContinue Reading
FRIDAY, July 14, 2023 (HealthDay News) — Racial discrimination may drive health inequities from an early age, according to researchers who found that it puts kids at risk for obesity. “Exposure to racial discrimination must be acknowledged as both a social determinant of obesity and a significant contributor to obesityContinue Reading